Hitachi, ThinkCyte to develop AI-driven cell analysis and sorting system
Singapore, July 5 -- Japan based companies Hitachi, Ltd. and ThinkCyte, Inc. have announced that they have entered into a collaboration focused on developing an artificial intelligence (AI)-driven cell analysis and sorting system.
Hitachi provides a broad range of solutions such as automated cell culture technologies to pharmaceutical companies in the value chain of the regenerative medicine and cell therapy industry.
Through the addition of this cell analysis and sorting system to the value chain, Hitachi continues contributing to cost reductions in the manufacturing of regenerative medicine and cell therapy products.
Further, Hitachi and ThinkCyte are promoting collaboration with pharmaceutical companies and research institutes worki...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.